Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. - Wikidata - wikimedia - TriplyDB

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

http://www.wikidata.org/entity/Q51465708

about

Independent and combined effect of diet and exercise in adults with prediabetes Aging, diabetes, and the public health system in the United States High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighbourhood--a population based study.Screening adults for pre-diabetes and diabetes may be cost-saving.Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review.Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial.Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007.Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.Measuring the sweet smell of success in diabetes management.Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance.Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts Systems science and childhood obesity: a systematic review and new directions.Screening for diabetes and prediabetes should be cost-saving in patients at high risk.Heterogeneity in cost-effectiveness of lifestyle counseling for metabolic syndrome risk groups -primary care patients in Sweden.Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study.Cost-effectiveness of alternative thresholds of the fasting plasma glucose test to identify the target population for type 2 diabetes prevention in adults aged ≥45 years.A culturally adapted lifestyle intervention addressing a Middle Eastern immigrant population at risk of diabetes, the MEDIM (impact of Migration and Ethnicity on Diabetes In Malmö): study protocol for a randomized controlled trial.Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study.Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.Prediabetes: the importance of early identification and intervention.Screening for type 2 diabetes and dysglycemia.Obesity and type 2 diabetes: which patients are at risk?Modelling the economics of type 2 diabetes mellitus prevention: a literature review of methods.A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program.A cost-effectiveness analysis of a community-based diabetes prevention program in Sweden.Projection of prediabetes and diabetes population size in Singapore using a dynamic Markov model.Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation.Isolated post-challenge hyperglycaemia and risk of cardiovascular events: Tehran Lipid and Glucose Study.Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.Cost-effectiveness of diabetes self-management programs in community primary care settings.Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies.

P2860

Q26828591-0D2D727C-8719-4DE7-94D6-CB85E3847C95 Q26852929-9CE3AB42-B772-47FE-B508-BA051FF8C15C Q33898833-ABA4019C-8F84-4098-9813-76D2FFA271D6 Q33932674-01D419B3-1383-4991-AC96-5A84703503DC Q34016162-EE5E0EB7-124A-4173-B12D-80CDB836F930 Q34119898-0CA37CC4-40C0-41F7-A1D1-D911393DC59B Q34123506-C78554B7-36F4-4D92-9960-47C1D7494FEC Q34196906-6A249AA1-B741-43E0-A05E-8AF814CC024E Q34658340-6BC8A91D-95EE-4540-878F-A379D799E0B3 Q35689542-139D5D36-9C99-4F9B-BC52-15D143B21E49 Q35841138-017F3BF3-6FBF-4451-869E-060CBB89A214 Q36412515-C4C34855-2E60-44D5-A491-49E9E3A3ECFD Q36423515-493A0F0B-5A61-40B5-89FD-22B0E17B52C9 Q36765489-F7E5E6FF-D265-4493-BBC0-89DF6F6F680A Q36848511-672AD88F-158D-444F-B9DE-E4466A7E5A51 Q36942092-90C0B5DB-DB1B-45D8-B469-E7778C842FFD Q37153047-0F357F27-B7CE-4796-804A-DA63DF35F235 Q37271291-1D5B951B-3E23-4467-B456-B1056853E282 Q37331119-3D1E478D-8F5C-4BAA-9916-D6D2182D4733 Q37352114-227B8449-3099-4035-9CAA-DA1B41DD7CBE Q37352594-822047AE-AF6D-47CD-B76D-00A980B756B3 Q37504139-D4852AAB-649A-4C89-A3D5-3B8F4FC63C04 Q37660219-24BC631C-8D9F-4569-8D98-49AFC52D47DE Q37700457-85CDD7E1-0C17-452D-A36A-E7DFA3D475E0 Q37777010-06FAF1A5-4851-4FFF-8BF1-6C26CAD18C4F Q37882225-9D574770-63CD-4099-B91F-C60B5DE89B4C Q37954693-4420A033-139F-4D20-A24D-8267073B68BE Q38193335-2F9C7091-1598-40EE-93B7-68DC9D67A9ED Q38788567-1F7C4DA4-2CD0-40A2-9ED4-E7A22DA92DC2 Q39961808-F2406196-43E8-465E-83D4-5AEA5DA4F857 Q40020513-B00A26BB-1E2B-40D7-91E2-E980A310BC57 Q41783780-998E3FCF-1471-41A3-A517-8F34B36511ED Q45398280-B26ED713-39D2-43A2-BC4E-34D9FFBD54E9 Q47160040-7234E6E2-E66B-4303-85E6-D60A684699A9 Q49120070-7EC945DA-988B-4EAD-BCCD-FEF16AED941A Q51365759-2B0296AE-1532-493B-A2F6-67B2FF6915F0

P2860

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

http://www.wikidata.org/entity/Q51465708

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

@en

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

@nl

type

label

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

@en

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

@nl

prefLabel

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

@en

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

@nl

P1433

Q51465708-E741B1FD-0DE4-4A54-968F-30925B0DC2C0

P1476

Q51465708-38C75775-639C-4A92-9EA4-CD01E8D09887

P2093

Q51465708-137BDC1B-5D35-4C50-9BA2-4F4C81224438

Q51465708-186879C1-0AB7-4FB9-9702-9FE28179B241

Q51465708-46F5A88E-1E03-4186-8B48-D46358623FD0

Q51465708-4FB3A258-F9A6-4088-A834-04E4654BB3A0

Q51465708-9D664C8D-E3BD-43ED-BB07-34924F40AA62

Q51465708-C8F0B8B0-045A-4CD9-8E05-1A2B49FB6C9B

Q51465708-CF377D49-B4BF-43CA-A667-DAC3B5582312

Q51465708-F6C74C3E-565A-49F5-AE80-1EDDCD85F534

P304

Q51465708-07C10004-2CE5-4912-83B7-6B5659A7DA17

P31

Q51465708-DE137A38-D4F8-48E5-A654-8F7AC89722B9

P356

Q51465708-48E22E3D-44DD-4F66-A873-93B916420B09

P407

Q51465708-2617A8AA-5CF9-4BAA-9ECA-279E3433CE29

P433

Q51465708-F5C0CFB0-2A14-49D7-8290-EC936F61B682

P478

Q51465708-C3F46381-A3B4-495C-AEF0-3A1BF001F4FA

P577

Q51465708-B55FB7EF-68DD-492E-A871-01B34897519A

P5875

Q51465708-5D6E90C4-5302-448B-962B-B06B0DEC4227

P698

Q51465708-E0EACA68-4712-48D8-A257-556AADA3081C

P921

Q51465708-B9ED0FC3-D7D9-45AE-B27C-9596F73068F3

P356

P1433

P1476

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

@en

P2093

Katherine A Hicks

http://www.w3.org/2001/XMLSchema#string

Michael M Engelgau

http://www.w3.org/2001/XMLSchema#string

Ping Zhang

http://www.w3.org/2001/XMLSchema#string

Robert E Ratner

http://www.w3.org/2001/XMLSchema#string

Ronald T Ackermann

http://www.w3.org/2001/XMLSchema#string

Stephen W Sorensen

http://www.w3.org/2001/XMLSchema#string

Thomas J Hoerger

http://www.w3.org/2001/XMLSchema#string

William H Herman

http://www.w3.org/2001/XMLSchema#string

P304

2874-2879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC07-0885

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6140270

http://www.w3.org/2001/XMLSchema#string

P698

17698614

http://www.w3.org/2001/XMLSchema#string

P921